pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 111

Radiology Marketing Genome Genomics 111

WCG Clinical

JUNE 28, 2023

Princeton, NJ, June 28, 2023 — WCG, one of the world’s leading providers of solutions that measurably improve the quality, efficiency, and safety of clinical research, recently announced a partnership with Mint Medical to leverage its mint Lesion™ radiology platform for oncology trials. in New Jersey, USA.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Radiology 97

Pharmaceutical Technology

NOVEMBER 30, 2022

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Vaccine 147

Vaccine Vaccination Development Gene Therapy 147

FDA Law Blog

OCTOBER 16, 2023

Can the FDA Keep them Safe”—focuses on FDA’s role in regulating clinical applications of AI/ML technologies and the impact of FDA’s regulatory requirements on the type of products developers choose to bring to market and how quickly they can be improved once there.

Radiology 119

Radiology Regulation Production Development 119

Roots Analysis

MAY 3, 2022

Blue ocean strategy, a concept first introduced in 2004, by W Chan Kim, and Renee Mauborgne in their bestselling book of the same name, talks about how to achieve a breakthrough in a highly saturated market by focusing on creating a new uncontested market. One of the thirteen strategic tools is strategy canvas. LinkedIn: [link].

Marketing 52

Marketing Radiology Drugs 52

pharmaphorum

OCTOBER 20, 2020

Demand for telehealth solutions like tele-ICU, tele-radiology, tele-pathology, to help virtual working of care professionals also drove growth in Q3. Frans van Houten also teased Philips’ financial 2021-2025 targets which will be released in full at its Capital Markets Day on 6 November.

Sales 105

Sales Radiology Medicine Production 105

Camargo

OCTOBER 8, 2020

While the sponsor initially planned to approach the Center for Radiological Health (CDRH), it soon became apparent that the combination product should be submitted to the Center for Drug Evaluation and Research (CDER). Camargo provided support by planning the key sections of the TPP to align sponsor goals, patient needs, and product labeling.

Production 130

Production Drugs Development Radiology 130

pharmaphorum

APRIL 16, 2021

It’s been working closely with Microsoft since 2019, and its main products – including Dragon Ambient eXperience (DAX), Dragon Medical One and PowerScribe One for radiology reporting – are all built on Microsoft’s Azure cloud platform. History in the making!

Radiology 92

Radiology Doctors Doctor Production 92

BioTech 365

SEPTEMBER 2, 2020

NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, … Continue reading → SOUTH JORDAN, Utah, Sept.

Radiology 40

Radiology Cardiology Manufacturing Marketing 40

The Pharma Data

FEBRUARY 21, 2022

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

Radiology 52

Radiology Cardiology Development Production 52

XTalks

OCTOBER 26, 2022

The life cycle of a medical device encompasses several phases, initiating from the spark of a feasible idea of the device’s design, followed by an analysis of patients’ need for the plausible device, development and validation of medical device’s design, approval from the regulatory agency, a launch of the device and finally post-market research.

Production 98

Production Radiology Marketing Development 98

FDA Law Blog

MAY 22, 2024

Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — We recently blogged about the Center for Devices and Radiological Health’s (CDRH) reluctance to make full use of real-world data (RWD) and real-world evidence (RWE) to support marketing applications.

Radiology 59

Radiology Regulation Marketing 59

XTalks

SEPTEMBER 9, 2022

George, MD, distinguished professor of Psychiatry, Radiology and Neuroscience, and director of the Brain Stimulation Division, Psychiatry at the Medical University of South Carolina, in Magnus Medical’s press release. SAINT is not the only neurostimulation system for depression to be recently cleared by the FDA.

Radiology 98

Radiology Life Science Licensing Licensing 98

The Pharma Data

OCTOBER 26, 2020

With this new joint venture, to be known as Arizona Diagnostic Radiology Group, RadNet has established an operating platform in the Phoenix metropolitan area, a rapidly growing market and home to almost five million people. RadNet’s core markets include California, Maryland, Delaware, New Jersey, New York, and now Arizona.

Radiology 40

Radiology Marketing Development Medicine 40

Delveinsight

JANUARY 14, 2021

Other Hallux Valgus marketed devices includes Lapidus Plating System (LPSTM) , which is approved for the correction of mild to extreme forefoot H.V., Besides Treace, Wright Medical Technology is also a major contender in the Hallux Valgus market. Hallux Valgus market for years now. subsequent bunions and related instability.

Marketing 40

Marketing Radiology Development Production 40

Advarra

MARCH 6, 2025

For more than 35 years, Advarra has been committed to protecting the rights and welfare of clinical trial participants while helping to improve healthcare outcomes, advancing medical knowledge, and bringing innovative, life-extending treatments to market that benefit millions of patients worldwide.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

FDA Law Blog

FEBRUARY 20, 2023

GoodRx has an estimated market capitalization of over $2 billion dollars. Through our FDA-focused lens, we see a possible roadmap as FDA’s Center for Devices and Radiological Health (CDRH) increases its resources, guidances, and enforcement emphases in the connected digital device space. The penalty of $1.5 million is, well, not a lot.

Radiology 105

Radiology Regulation Compliance Marketing 105

XTalks

APRIL 27, 2021

The US Food and Drug Administration (FDA) has authorized marketing of a new neurological rehabilitation device to assist in maintaining or increasing range of motion as part of muscle re-education in patients undergoing stroke rehabilitation. The device is approved for use in patients 18 years of age and older.

Radiology 105

Radiology Development FDA Approval Containment 105

XTalks

APRIL 7, 2021

The new, revised EUA will allow the company to market the test for the qualitative detection of SARS-CoV-2 from nasal swab samples for screening use with serial testing. The EUA allows for the marketing of the device in the US.

Antibody 102

Antibody Immune Response Radiology Marketing 102

The Pharma Data

SEPTEMBER 16, 2020

The move is intended to increase flexibility for health labs to make tests available through the market. These claims were dismissed by HHS Chief of Staff Brian Harrison, who said that: “Every interaction between the secretary and commissioner has been highly professional.”. Matt Fellows. Source link.

Radiology 52

Radiology Marketing Development Medicine 52

Pharma Packaging Solutions

OCTOBER 29, 2024

Navigating the Regulatory Landscape In the United States, the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) lays down strict regulations that govern medical device packaging. Essential Packaging Requirements Examining the arena of packaging requirements reveals many considerations.

Packaging 52

Packaging Packaging Regulation Pharma Packaging 52

FDA Law Blog

AUGUST 18, 2024

In effect, these documents serve as road signs helping to direct new market entrants. Sponsors of a new 510(k) device can use the decision summary and classification order affiliated with the De Novo to learn what the De Novo applicant submitted and build the case for substantial equivalence to the De Novo device.

In-Vitro 69

In-Vitro Radiology Cosmetics Medicine 69

XTalks

FEBRUARY 10, 2021

The US Food and Drug Administration (FDA) has granted marketing authorization to Signifier Medical Technologies ’ sleep apnea treatment device, called eXciteOSA. The new device is designed to reduce snoring and treat mild obstructive sleep apnea (OSA) in individuals 18 years and older, and is available by prescription only. How it Works.

Radiology 97

Radiology Marketing Clinical Trials Clinical Trials 97

The Pharma Data

OCTOBER 19, 2020

Adventist Health is pleased to partner with RadNet, the nation’s leading outpatient radiology provider. RadNet’s core markets include California, Maryland, Delaware, New Jersey, New York, and now Arizona. RadNet, Inc. RadNet has a network of 332 owned and/or operated outpatient imaging centers.

Radiology 40

Radiology Production Marketing 40

Worldwide Clinical Trials

JULY 8, 2024

Similar to the FDA, the EMA evaluates radiopharmaceuticals for safety, efficacy, quality, and GMP regulation compliance before granting marketing authorization. International Commission on Radiological Protection (ICRP) The ICRP provides recommendations and guidance on radiation protection standards for occupational and public exposure.

Hormones 130

Hormones Regulation Clinical Trials Clinical Trials 130

XTalks

APRIL 19, 2024

Both tools represent Avicenna.AI’s focus on developing tools that integrate AI within the radiology workflow, improving the speed and accuracy of medical diagnostics. According to GlobalData , the global AI in healthcare market was valued at $81.3 AI in medical imaging is a large segment driving the market. percent and 24.2

Marketing 52

Marketing Radiology Development Manufacturing 52

The Pharma Data

OCTOBER 1, 2021

Currently, the quality dose for all marketed GBCAs, including gadobutrol and gadoterate, is 0.1 Dr. Olaf Weber, Head of Radiology Research and Development at Bayer. About Radiology at Bayer Everyone deserves clear answers about their health, starting with an early and accurate diagnosis. mmol/kg weight. “At

Radiology 52

Radiology Life Science Development Production 52

The Pharma Data

DECEMBER 14, 2020

Program grants are awarded to companies with promising technologies that have a strong potential for commercialization, to help translate life-saving innovations to consumer markets and create jobs in biotechnology. About Alume Biosciences, Inc. ————-. This award was granted by the National Institutes of Health.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Radiology 52

pharmaphorum

MARCH 16, 2022

In the pharmaceutical industry digital marketing is nothing new, but in the context of onsite-and-online events it is. That said, the industry has accrued substantial experience of virtual engagement with healthcare professionals dating back for at least 25 years. Will it focus more on onsite, more on online, or on both options equally?

Doctors 98

Doctors Doctor Marketing Radiology 98

pharmaphorum

MARCH 31, 2021

It enters an increasingly crowded MS market, but will compete most closely with Roche’s $4.3 billion blockbuster CD20 drug Ocrevus (ocrelizumab) which is given by infusion. Analysts say Kesimpta could make $1.3 billion or more in peak sales.

Licensing 98

Licensing Licensing Gene Therapy Sales 98

pharmaphorum

OCTOBER 4, 2022

On 27th September 2022, the Food and Drug Administration (FDA) issued its final guidance for industry and FDA staff clinical decision support (CDS) software, which has been anticipated since the Center for Devices and Radiological Health (CDRH) listed the guidance as a top priority for fiscal year 2022. Criterion 2.

Development 105

Development Regulation Cosmetics Life Science 105

The Pharma Data

NOVEMBER 28, 2020

TeraRecon’s end-to-end AI ecosystem, including the Eureka AI Results Explorer, AI interoperability platform, and Intuition advanced visualization technologies will be exhibited during the upcoming Radiological Society of North America’s 2020 Annual Scientific Virtual Session from Sunday, November 29 th – Saturday, December 5 th.

Radiology 40

Radiology Marketing Production Development 40

FDA Law Blog

AUGUST 7, 2023

By Véronique Li, Senior Medical Device Regulation Expert — The Center for Devices and Radiological Health (CDRH) offers learning opportunities for new and experienced CDRH staff through the Experiential Learning Program (ELP). It was also helpful to hear first-hand the practical challenges companies navigate in bringing products to market.

Radiology 40

Radiology Production Regulation Manufacturing 40

XTalks

MARCH 30, 2021

An innovative new non-surgical medical device called the portable neuromodulation stimulator (PoNS) has received marketing authorization from the US Food and Drug Administration (FDA) as a treatment to help improve gait in patients with multiple sclerosis (MS). MS affects patients differently with respect to both symptoms and their severity.

Radiology 71

Radiology Trials Marketing Containment 71

Cloudbyz

JULY 31, 2024

This revolution is enabling the growth of innovative biomarker-based precision medicine and cell and gene therapy, transforming both clinical research and post-market care. Personalized Post-Treatment Plans: Post-market diagnostics enable the customization of post-treatment care plans based on individual patient responses.

Gene Therapy 52

Gene Therapy Gene Medicine In-Vitro 52

pharmaphorum

AUGUST 4, 2020

Like others it has also been hit by the effects of lockdowns on prescribing rates in the second quarter – with women’s health, ophthalmology and radiology products hit the hardest as consultation rates plummeted – but says it saw glimmers of a recovery at the end of the period.

Sales 52

Sales Radiology Production Medicine 52

pharmaphorum

SEPTEMBER 30, 2022

Assuming the FDA decides that the efficacy and safety data for lecanemab is strong, it could opt to approve the drug via the accelerated approval mechanism – with a decision on that due by 6 January – or wait to review the full marketing application, including the Clarity AD results that will be submitted in the first quarter of next year.

Clinical Trials 52

Clinical Trials Clinical Trials Sales Drugs 52